Optimal use of proton pump inhibitors for treating acid peptic diseases in primary care

被引：0

作者：

Tack, J. ^{[1
]}

Louis, E. ^{[2
,3
]}

Persy, V. ^{[4
]}

Urbain, D. ^{[5
]}

机构：

[1] Katholieke Univ Leuven, Translat Res Ctr Gastrointestinal Disorders, B-3000 Louvain, Belgium

[2] CHU, Liege, Belgium

[3] Univ Liege, Liege, Belgium

[4] Hugin Mugin Res, Antwerp, Belgium

[5] Vrije Univ Brussel, UZ Brussel, Dept Gastroenterol, Brussels, Belgium

来源：

ACTA GASTRO-ENTEROLOGICA BELGICA | 2013年 / 76卷 / 04期

关键词：

Proton pump inhibitors; acid peptic diseases; best practices; review; GASTROESOPHAGEAL-REFLUX DISEASE; FUNCTIONAL DYSPEPSIA; HELICOBACTER-PYLORI; CLINICAL-TRIALS; ESOPHAGEAL PH; PPI THERAPY; LIFE-STYLE; SYMPTOMATIC PATIENTS; GENERAL-POPULATION; DOUBLE-BLIND;

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Heartburn, reflux and epigastric pain are frequently encountered symptoms in primary care medicine. Acid peptic diseases such as peptic ulcer and gastrointestinal reflux disease have a high prevalence, can have important impact on patient quality of life and represent a considerable health care cost. Proton pump inhibitors (PPIs) are the most potent pharmacological inhibitors of gastric acid secretion currently available and are the mainstay medical therapy for acid peptic diseases. This review summarizes current evidence on treatment of acid-peptic diseases with proton pump inhibitors and provides primary care clinicians with best practice guidelines for optimal use of these drugs.

引用

页码：393 / 402

页数：10

共 50 条

[31] Use of proton pump inhibitors in general practice
Cesare Tosetti
Ilaria Nanni
World Journal of Gastrointestinal Pharmacology and Therapeutics, 2017, (03) : 180 - 185
[32] The role of the pharmacist in the selection and use of over-the-counter proton-pump inhibitors
Boardman, Helen F.
Heeley, Gordon
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (05) : 709 - 716
[33] Risk of Complications After a Peptic Ulcer Diagnosis: Effectiveness of Proton Pump Inhibitors
Hernandez-Diaz, Sonia
Martin-Merino, Elisa
Garcia Rodriguez, Luis A.
DIGESTIVE DISEASES AND SCIENCES, 2013, 58 (06) : 1653 - 1662
[34] Prevalence of rebleeding from peptic ulcer in patients treated with proton pump inhibitors
Garrido, Antonio
Isabel Iborra, Maria
Saperas, Esteban
de Sousa, Monica
MEDICINA CLINICA, 2010, 134 (13): : 577 - 582
[35] Predictors for inappropriate proton pump inhibitor use: observational study in primary care
Koggel, Lieke Maria
Lantinga, Marten Alexander
Buchner, Frederike Leonie
Drenth, Joost Paulus Hubertus
Frankema, Jacqueline Sarah
Heeregrave, Edwin Johannes
Heringa, Mette
Numans, Mattijs Everard
Siersema, Peter Derk
BRITISH JOURNAL OF GENERAL PRACTICE, 2022, 72 (725): : E899 - E906
[36] Comparison of different regimens of proton pump inhibitors for acute peptic ulcer bleeding
Neumann, Ignacio
Letelier, Luz M.
Rada, Gabriel
Carlos Claro, Juan
Martin, Janet
Howden, Colin W.
Yuan, Yuhong
Leontiadis, Grigorios I.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (06):
[37] Risk of Complications After a Peptic Ulcer Diagnosis: Effectiveness of Proton Pump Inhibitors
Sonia Hernández-Díaz
Elisa Martín-Merino
Luis A. García Rodríguez
Digestive Diseases and Sciences, 2013, 58 : 1653 - 1662
[38] Meta-analysis of proton pump inhibitors in treatment of bleeding peptic ulcers
Zed, PJ
Loewen, PS
Slavik, RS
Marra, CA
ANNALS OF PHARMACOTHERAPY, 2001, 35 (12) : 1528 - 1534
[39] Role of Acid Suppression in Acid-related Diseases: Proton Pump Inhibitor and Potassium-competitive Acid Blocker
Mori, Hideki
Suzuki, Hidekazu
JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2019, 25 (01) : 6 - 14
[40] Magnitude and Determinants of Long-term Use of Proton Pump Inhibitors Among Portuguese Older Adults in Primary Health Care
Rodrigues, Daniela A.
Herdeiro, Maria Teresa
Mateos-Campos, Ramona
Figueiras, Adolfo
Roque, Fatima
CLINICAL THERAPEUTICS, 2024, 46 (02) : e54 - e58

← 1 2 3 4 5 →